Funded Tech Companies
Tolremo therapeutics
Tolremo therapeutics, based in Basel, received investment capital from Pierre Fabre and BioMedPartners.
Company Overview
Company Name
Tolremo therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Hochbergerstrasse 60C
Basel, CH-4057
CH
Basel, CH-4057
CH
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
TOLREMO therapeutics' mission is to prevent non-genetic cancer drug resistance by dismantling the earliest defense to targeted therapies. Led by phenotypic insights, we discovered a pivotal mechanism that governs critical transcriptional resistance pathways. Our clinical compound TT125-802 is an orally available small molecule inhibitor designed to block these survival techniques to significantly improve the response rates and durability of established treatments.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/20/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stefanie Mangual
Chief Operating Officer
Claudia Escher
Company Investors
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs